SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
UCB, Inc. Announces New Data to Increase Understanding of Short- and Long-Term Clinical Profile of Antiepileptic Drug VIMPAT® (lacosamide)